- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:07 | Aclarion, Inc.: Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash | 7 | GlobeNewswire (USA) | ||
| 14.11. | Aclarion, Inc.: Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st | 197 | ACCESSWIRE | BROOMFIELD, CO / ACCESSWIRE / November 14, 2024 / Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq:ACON)(Nasdaq:ACONW), a healthcare technology company that is leveraging biomarkers and proprietary... ► Artikel lesen | |
| 14.11. | Aclarion, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 25.10. | Aclarion, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 14.10. | Aclarion, Inc. droht Delisting von der Nasdaq aufgrund von Compliance-Problemen | 1 | Investing.com Deutsch | ||
| 14.10. | Aclarion, Inc. faces Nasdaq delisting over compliance issues | 3 | Investing.com | ||
| ACLARION Aktie jetzt für 0€ handeln | |||||
| 11.10. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.10. | Aclarion, Inc.: Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit | 1 | GlobeNewswire (USA) | ||
| 01.10. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.09. | Aclarion-Studie verbindet Rückenschmerzen mit MRT-nachgewiesenen Veränderungen | 1 | Investing.com Deutsch | ||
| 27.09. | Aclarion, Inc.: Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes | 2 | GlobeNewswire (USA) | ||
| 24.09. | Aclarion, Inc. startet At-the-Market-Angebot über 10 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 24.09. | Aclarion, Inc. initiates $10 million at-the-market offering | 2 | Investing.com | ||
| 23.09. | Aclarion shareholders approve reverse stock split proposal | 2 | Investing.com | ||
| 23.09. | Aclarion-Aktionäre stimmen Vorschlag für Aktienzusammenlegung zu | 2 | Investing.com Deutsch | ||
| 23.09. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.09. | Aclarion, Inc.: Aclarion Provides Corporate Update on Nociscan AI Technology Milestones | 321 | GlobeNewswire (Europe) | Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing... ► Artikel lesen | |
| 10.09. | Aclarion, Inc.: Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial | 203 | GlobeNewswire (Europe) | Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled Trial... ► Artikel lesen | |
| 05.09. | Aclarion, Inc.: Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market | 1 | GlobeNewswire (USA) | ||
| 29.08. | Aclarion, Inc.: Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| NANO-X IMAGING | 5,620 | -4,58 % | Nano-X Imaging Ltd reports results for the quarter ended September 30 - Earnings Summary | ||
| BUTTERFLY NETWORK | 3,455 | +3,91 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| GOODRX | 4,320 | +0,23 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,140 | -0,63 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,350 | +0,35 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
| MIMEDX | 9,145 | +0,83 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 92,70 | 0,00 % | PROCEPT started with Hold at Jefferies on valuation | ||
| HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| BIOMERICA | 0,311 | -2,81 % | Biomerica secures patents for GI treatments in Europe | ||
| PROGYNY | 14,020 | +0,29 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
| ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| LIFEMD | 5,450 | +0,93 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| PROPHASE LABS | 0,690 | +0,73 % | ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript |
ACLARION INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,175 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.
